SightfileU.S. market data from official filings

Companies › TVRD

TVARDI THERAPEUTICS INC COM (TVRD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001346830 · EDGAR filings · Updated 2026-07-17

TVARDI THERAPEUTICS INC COM (TVRD) has reported institutional ownership of 28.8%, with 67 institutional managers holding positions valued at $8.60M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
28.8%
Institutional managers
67
Reported 13F value
$8.60M
Insider activity
11 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TVARDI THERAPEUTICS INC COM has 67 institutional holders and institutional ownership of 28.8%.

Insider activity

Insiders reported 11 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-08 (recurring since 2025-05-13) — source filing. The authoritative details are those stated in the filing itself.

Related companies

METAGENOMI THERAPEUTICS INC (MGX) · MYOMO INC (MYO) · Curis Inc (CRIS) · RENOVORX INC (RNXT) · Bausch Lomb Corp (BLCO) · SS INNOVATIONS INTERNATIONAL COM NEW (SSII)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.